Growth Metrics

Biomerica (BMRA) Operating Leases (2019 - 2025)

Biomerica recorded quarterly Operating Leases of $373000.0 in Q3 2025, up 273.0% quarter-over-quarter from $100000.0 in Q2 2025, and down 47.24% year-over-year from $707000.0 in Q3 2024.

Biomerica's Operating Leases history runs 7 years deep, the most recent figure standing at $373000.0 for Q3 2025.

  • In Q3 2025, Operating Leases fell 47.24% year-over-year to $373000.0; the TTM figure through Aug 2025 stood at $373000.0 (down 47.24% YoY), while the FY2025 annual figure was $100000.0, down 78.21% from the prior year.
  • Operating Leases came in at $373000.0 for Q3 2025 at Biomerica, up from $100000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.4 million in Q1 2022 to a low of $100000.0 in Q2 2025.
  • A 5-year average of $860307.2 and a median of $901449.0 in 2022 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases climbed 6.83% in 2022 and tumbled 78.21% in 2025, its largest moves.
  • Biomerica's Operating Leases stood at $1.2 million in 2021, then retreated by 22.74% to $901449.0 in 2022, then advanced by 3.94% to $937000.0 in 2023, then tumbled by 33.19% to $626000.0 in 2024, then tumbled by 40.42% to $373000.0 in 2025.
  • According to Business Quant data, Operating Leases over the past three periods registered $373000.0, $100000.0, and $193000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Biomerica 7.12 Mn 5.78 Mn -44,000.00

Historic Data

Download Data 🔒
DateValue
Aug 31, 2025 373,000.00
May 31, 2025 100,000.00
Feb 28, 2025 193,000.00
Nov 30, 2024 626,000.00
Aug 31, 2024 707,000.00
May 31, 2024 459,000.00
Feb 29, 2024 543,000.00
Nov 30, 2023 937,000.00
Aug 31, 2023 1.01 Mn
May 31, 2023 785,000.00
Feb 28, 2023 828,944.00
Nov 30, 2022 901,449.00
Aug 31, 2022 1.32 Mn
May 31, 2022 1.04 Mn
Feb 28, 2022 1.44 Mn
Nov 30, 2021 1.17 Mn
Aug 31, 2021 1.23 Mn
May 31, 2021 1.29 Mn
Feb 28, 2021 1.40 Mn
Nov 30, 2020 1.45 Mn
Aug 31, 2020 1.51 Mn
May 31, 2020 1.57 Mn
Feb 29, 2020 1.62 Mn
Nov 30, 2019 1.68 Mn
Aug 31, 2019 1.73 Mn